0 Comments
0 Shares
463 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Precision Oncology Drugs: The Evolving NRG1 Fusion Market for Targeted Cancer TherapeuticsThe field of precision oncology has advanced significantly, with targeted therapies offering new treatment options for patients with genetically defined cancers. Among the most promising targets are rare gene fusions, including NRG1 fusions, which are found in a small but significant subset of solid tumors. The precision oncology drugs market is experiencing substantial growth, with...0 Comments 0 Shares 534 Views 0 Reviews
-
Anti-cancer Drugs Market Trends in Personalized and Targeted Oncology SolutionsThe Cancer remains one of the leading causes of mortality worldwide, driving pharmaceutical companies and healthcare providers to focus on the development of highly effective anti-cancer drugs. Technological advancements in drug discovery, increased adoption of precision medicine, and favorable regulatory support are accelerating the commercialization of next-generation oncology therapies....0 Comments 0 Shares 880 Views 0 Reviews
-
Generic Oncology Drugs Market Demand Analysis and Business Opportunities 2031The Generic Oncology Drugs Market is projected to reach US$ 42.43 Billion by 2031, registering a CAGR of 6.3% during the forecast period. The market is expanding as healthcare systems seek cost-effective cancer treatment options while the global burden of cancer continues to increase. Growth is supported by the rising incidence of cancer, increasing healthcare expenditure,...0 Comments 0 Shares 28 Views 0 Reviews
-
Generic Oncology Drugs Market Forecast 2031: Market Value Projected at US$ 42.43 BillionThe global Generic Oncology Drugs Market is witnessing remarkable growth due to the increasing prevalence of cancer worldwide and the rising demand for affordable treatment options. Healthcare systems across developed and emerging economies are actively adopting generic oncology drugs to reduce the financial burden associated with cancer therapies. The growing number of patent expirations for...0 Comments 0 Shares 462 Views 0 Reviews
-
Hepatocellular Carcinoma Drugs Market Strengthens with New Drug Approvals and Advancements in Oncology Research"Executive Summary Hepatocellular Carcinoma Drugs Market Size and Share Across Top Segments CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.20%, primarily driven by advancements in diagnostic techniques This global Hepatocellular Carcinoma Drugs Market report identifies and analyses the emerging trends along with major...0 Comments 0 Shares 943 Views 0 Reviews
-
How Oncology Innovation Is Creating New Opportunities in the Platinum-Based Cancer Drugs MarketPolaris Market Research presents its latest market research report, titled Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region – Market Forecast, 2026–2034. It is a comprehensive market research report analyzing the fast-evolving...0 Comments 0 Shares 106 Views 0 Reviews
-
How the Oncology Drugs Market is Positioned for Exponential GrowthThe Oncology Drugs Market is undergoing significant transformation, with a remarkable projected growth trajectory. By 2035, the market is forecasted to reach an impressive $763.21 billion, reflecting a compound annual growth rate (CAGR) of 14.2%. This growth is driven by an increase in cancer cases globally, a rise in innovative therapies, and the growing prevalence of personalized medicine. As...0 Comments 0 Shares 173 Views 0 Reviews
-
Liposomal Drugs Market Accelerates with Targeted Drug Delivery and Oncology Innovations" According to the latest report published by Data Bridge Market Research, the Liposomal Drugs Market CAGR Value Global liposomal drugs market size was valued at USD 5.31 billion in 2024 and is projected to reach USD 10.21 billion by 2032, with a CAGR of 8.50% during the forecast period of 2025 to 2032. To impart a supreme quality to this persuasive Liposomal Drugs...0 Comments 0 Shares 472 Views 0 Reviews
-
North America Oncology Drugs Market Benefits from Rapid Adoption of Immunotherapy TreatmentsThe North America Oncology Drugs Market represents one of the largest and most advanced regional markets globally. The region benefits from a robust healthcare infrastructure, substantial oncology research investments, and the presence of leading pharmaceutical and biotechnology companies. Rising cancer incidence, favorable reimbursement policies, and rapid adoption of innovative therapies such...0 Comments 0 Shares 297 Views 0 Reviews
-
Oncology Blockbuster Drugs Market: Breakthrough Therapies and Commercial TrendsAccording to the latest report published by Data Bridge Market Research, the Oncology Blockbuster Drugs Market CAGR Value Global oncology blockbuster drugs market size was valued at USD 31.99 billion in 2024 and is projected to reach USD 63.49 billion by 2032, with a CAGR of 8.00% during the forecast period of 2025 to 2032. This Oncology Blockbuster Drugs Market document...0 Comments 0 Shares 219 Views 0 Reviews
-
Oncology Drugs Industry: Market Size, Trends & Growth ForecastThe global Oncology Drugs Market is anticipated to experience substantial growth from 2025 to 2033, driven by the rising global burden of cancer, increasing healthcare expenditure, advancements in precision medicine, and growing adoption of targeted therapies and immunotherapies. With an estimated valuation of approximately USD 253.6 billion in 2025, the market is expected to...0 Comments 0 Shares 66 Views 0 Reviews
-
Dasatinib Market Growth in Emerging Healthcare MarketsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Comments 0 Shares 1K Views 0 Reviews
-
Advanced Therapeutics and Precision Medicine Fuel Expansion of the High Potent Pharmaceuticals Product Market 2031The high potent pharmaceuticals product market is witnessing strong global momentum as the healthcare industry increasingly shifts toward targeted therapies and precision-based treatments. These pharmaceutical products are characterized by their ability to deliver highly effective therapeutic outcomes at very low doses, making them essential in treating complex diseases such as cancer, hormonal...0 Comments 0 Shares 2K Views 0 Reviews
-
Anal Cancer Market Size Projected to Reach USD 978.10 Million by 2032“According to a new report published by Introspective Market Research, Anal Cancer Market by Cancer Type, Treatment Type, and End User, The Global Anal Cancer Market Size Was Valued at USD 638.11 Million in 2023 and is Projected to Reach USD 978.10 Million by 2032, Growing at a CAGR of 4.86% From 2024–2032.” The Anal Cancer Market is witnessing steady growth due to rising...0 Comments 0 Shares 2K Views 0 Reviews
-
Anti-Emetic Drugs Market Size, Share, and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Anti-Emetic Drugs Market Data Bridge Market Research analyses that the global anti-emetic drugs market which was USD 7,543.13 million in 2022, is expected to reach USD 12,840.23 million by 2030, and is expected to undergo a CAGR of 6.06% during the forecast period of 2023 to 2030. “D2 Receptors”...0 Comments 0 Shares 2K Views 0 Reviews
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer...0 Comments 0 Shares 2K Views 0 Reviews
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer Market...0 Comments 0 Shares 12K Views 0 Reviews
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 2K Views 0 Reviews
-
Breast Cancer Drugs Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Comments 0 Shares 9K Views 0 Reviews
-
Cell Therapy Manufacturing Market: Global Growth & AnalysisIntrospective Market Research, a global authority in biotechnology and healthcare analysis, today released its comprehensive report on the Global Cell Therapy Manufacturing Market. This critical sector, which encompasses the complex processes of cell acquisition, culture, expansion, and testing for regenerative medicine, is transitioning from a niche laboratory process to an industrialized...0 Comments 0 Shares 3K Views 0 Reviews
-
Cytotoxic Drugs Market Size, Share, Trends & Forecast to 2032According to the latest report published by Data Bridge Market Research, the Cytotoxic Drugs Market Global cytotoxic drugs market size was valued at USD 17.59 billion in 2024 and is projected to reach USD 42.11 billion by 2032, with a CAGR of 7.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate,...0 Comments 0 Shares 3K Views 0 Reviews
-
Emerging Innovations and Growth Trajectory in Adult Malignant Glioma Therapeutics Market: Trends, Analysis, and Forecast to 2031The global oncology landscape is undergoing rapid transformation, driven by increasing prevalence of aggressive brain tumors such as malignant gliomas in adults. The rising incidence of glioblastoma, combined with advancements in precision medicine and immunotherapy, is significantly reshaping treatment approaches. Continuous innovation in drug development, coupled with increasing investment in...0 Comments 0 Shares 1K Views 0 Reviews
More Results
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali